Seqomics
Generated 5/9/2026
Executive Summary
Seqomics is a Hungarian biotechnology company founded in 2005, specializing in genetics and genomics services. The company provides next-generation sequencing, bioinformatics, and specialized testing for food safety and animal health. It also engages in academic and clinical research, contributing to numerous scientific publications. As a private entity based in Mátészalka, Hungary, Seqomics operates as a service provider and research organization, serving clients in the biotech and agri-food sectors. With no disclosed funding rounds or valuation, the company appears to be a self-sustained niche player. Its long-standing presence since 2005 and active research involvement indicate technical expertise, though its scale and market reach remain limited. The company's focus on animal health and food safety testing positions it to benefit from increasing EU regulations on food traceability and animal disease surveillance. However, without clear commercial products or partnerships, Seqomics faces challenges in scaling beyond its regional base. Overall, Seqomics is a modest but established service-oriented genomics firm with potential for gradual growth in specialized testing niches.
Upcoming Catalysts (preview)
- Q3 2026Launch of expanded food safety testing panel for EU markets60% success
- Q2 2026Publication of clinical research results in collaboration with Hungarian universities75% success
- Q4 2026Strategic partnership for animal health genomics with veterinary diagnostics company40% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)